Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma
NCT01857115Phase 2Completed
- Start
- Apr 2013
- Primary completion
- Nov 2013
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM). Started Apr 2013; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01857115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857115.